The effect of diclofenac suppository in the use of drugs to reduce pain in patients undergoing colonoscopy

Evaluation of Effectiveness of sodium diclofenac suppository in reduction of pain and dosage of narcotic in patients undergoing colonoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016092629976N1

Enrollment

526

Registered

2016-10-10

Start date

2016-08-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain. Acute pain

Interventions

Intervention 1: In the Control group, (5 mg, Daroupakhsh company, Iran) and Fentanyl (500 µg, Daroupakhsh company, Iran) with adding placebo was prescribed. Intervention 2: In the intervention group,

Treatment - Drugs

In the Control group, (5 mg, Daroupakhsh company, Iran) and Fentanyl (500 µg, Daroupakhsh company, Iran) with adding placebo was prescribed.

In the intervention group, standard regimen include midazolam (5 mg, Daroupakhsh company, Iran) and Fentanyl (500 µg, Daroupakhsh company, Iran) with adding diclofenac suppository (100 mg, Daroupakhsh

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria:Colonoscopy candidate; consent to participate in the study Exclusion criteria:Patients who feared colonoscopy; patients with history of previous surgery; inflammatory bowel disease; cardiopulmonary comorbidities; history of NSAID hypersensitivity; in situation of their contraindication

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Discomfort and pain. Timepoint: End of colonoscopy. Method of measurement: visual analogue scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParviz Amri maleh

Babol University Of Medical Sciences

pamrimaleh@gmail.com+98 11 3223 8284

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026